Accuracy of Three Commercial Home-Use HbA1c Tests.

Laura Jacobsen,Laura Bocchino,John Lum,Craig Kollman,Victoria Barnes-Lomen,Mark Sulik,Michael Haller,Bruce Bode,Joseph Cernich,Anthony Killeen,Uttam Garg,David R Lilenquist,Janey Adams,Margaret Clements,Deanna Gabrielson,Terri Johnson,Mark A Clements,Roy W Beck

Diabetes technology & therapeutics（2022）

引用 0|浏览11

暂无评分

摘要

None of the commercial home-use HbA1c tests produced the National Glycohemoglobin Standardization Program goal of ≥90% measurements within 5% of a DCCT venous reference. However, the Home Access product performed substantially better than the CoreMedica or A1cNow+ products. Telemedicine is likely to persist as a mainstay of diabetes care well after the COVID-19 era. As such, accurate home-based HbA1c assessment represents an urgent need for the diabetes community.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要